hyperuricemia


Also found in: Medical, Encyclopedia, Wikipedia.
Related to hyperuricemia: purine, uric acid

hy·per·u·ri·ce·mi·a

 (hī′pər-yo͝or′ĭ-sē′mē-ə)
n.
The presence of an abnormally high concentration of uric acid in the blood, as in gout.

hy•per•u•ri•ce•mi•a

(ˌhaɪ pərˌyʊər əˈsi mi ə)

n.
an excess of uric acid in the blood.
[1890–95]
hy`per•u`ri•ce′mic, adj.
Translations

hy·per·u·ri·ce·mi·a

n. hiperuricemia, exceso de ácido úrico en la sangre.

hyperuricemia

n hiperuricemia
Mentioned in ?
References in periodicals archive ?
Members of the Food and Drug Administration's Arthritis Advisory Committee have voted in favor of recommending approval of the investigational uricosuric drug lesinurad at 200 mg daily for the proposed indication of treatment of hyperuricemia associated with gout in combination with a xanthine oxidase inhibitor, such as allopurinol or febuxostat.
Each brochure includes information about the specific health issue and link between gout and hyperuricemia, as well as strategies for controlling gout and protecting long-term health.
Riparoside B and timosaponin J may have a clinical utility in treating gout and other medical conditions caused by hyperuricemia.
The TFP also recommended that patients be assessed for a "checklist" of comorbidities commonly seen in gout patients, because these may contribute to or be affected by hyperuricemia (e.
In this article, we report a 30-year-old female case of tophaceous gout with atypical localization presenting without hyperuricemia or an acute inflammatory gout attack.
The study found that a baseline adherence to a Mediterranean diet (MeDiet) is associated with a lower risk of hyperuricemia, The Indian Express reported.
Washington, April 19 ( ANI ): A baseline adherence to a Mediterranean diet (MeDiet) was found to be associated with a lower risk of hyperuricemia, defined as a serum uric acid (SUA) concentration higher than 7mg/dl in men and higher than 6mg/dl in women, according to a study.
one case of hyperuricemia at the 240 mg dose and three cases of
Teijin Pharma to expand global marketing of hyperuricemia drug
Objective: This study aimed to examine the incidence, clinical characteristics, and outcome of hyperuricemia and tumor lysis syndrome (TLS) in children with non-Hodgkin's lymphoma (NHL) and acute lymphoblastic leukemia (ALL).
Tokyo, Jan 21, 2011 - (JCN Newswire) - Teijin Pharma Limited, the core company of the Teijin Group's medical and pharmaceutical business, announced today that Japan's Ministry of Health, Labour and Welfare approved TMX-67 (febuxostat), Teijin Pharma's novel drug for treating hyperuricemia, on January 21.